… evaluated clopidogrel-aspirin as a treatment to prevent stroke after a minor stroke or high-risk
TIA. The … Prespecified variables included age, sex, race, previous ischemic heart disease, …

… more effective than aspirin for preventing serious vascular events in patients at high risk [5]. …
This might confer higher risk of clopidogrel resistance in our study subject. A recent meta-…

… aspirin for secondary prevention of cardiovascular disease (class I, level A recommendation),
and clopidogrel as an alternative in case of aspirin … Particularly in patients with high risk …

… The risk of ischemic stroke and other major vascular events … While we found PPI use to be
suggestive of a higher risk of major … 1000 patients treated, adding clopidogrel might prevent …

… major vascular events in patients with … Prevent Early Recurrence) trials, there was higher
risk of major bleeding with A+C therapy in aspirin-naïve patients as compared with the patients …

… may not provide additional benefit in stroke prevention compared with aspirin alone for the
… alleles were at higher risk of vascular events than non-carriers when taking clopidogrel.7 …

… in patients with stable cardiovascular disease. The main strength in comparison with previous
analyses is that the study incorporates evidence not only with clopidogrel … , clopidogrel is …

… by clopidogrel monotherapy without aspirin, as the treatment of choice for those at very high
risk of … for a select group of primary prevention patients who are at higher risk of CVD but low …

… inferior to clopidogrel in preventing recurrent adverse cardiovascular … aspirin is continually
used throughout. However, in CAD patients with high risk of bleeding, the use of clopidogrel is …

… prevent major adverse cardiovascular events. However, patients treated with CABG still have
a notable risk of … There was no evidence of a higher risk of major bleeding among patients …